These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 25374283

  • 1. Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution Experience.
    Berlanga P, Cañete A, Díaz R, Salom M, Baixauli F, Gómez J, Llavador M, Castel V.
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):e272-7. PubMed ID: 25374283
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, Branscheid D, Kotz R, Salzer-Kuntschik M, Winkelmann W, Jundt G, Kabisch H, Reichardt P, Jürgens H, Gadner H, Bielack SS, Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
    J Clin Oncol; 2003 May 15; 21(10):2011-8. PubMed ID: 12743156
    [Abstract] [Full Text] [Related]

  • 4. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
    Lin L, Deng S, Zhang F, Liang Y, Huang Z.
    World J Surg Oncol; 2018 Feb 23; 16(1):39. PubMed ID: 29471883
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
    Boye K, Del Prever AB, Eriksson M, Saeter G, Tienghi A, Lindholm P, Fagioli F, Skjeldal S, Ferrari S, Hall KS.
    Pediatr Blood Cancer; 2014 May 23; 61(5):840-5. PubMed ID: 24254749
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B, Tu J, Yin J, Zou C, Wang J, Huang G, Xie X, Shen J.
    Oncotarget; 2015 Nov 10; 6(35):38348-59. PubMed ID: 26435480
    [Abstract] [Full Text] [Related]

  • 11. A study of 28 flat bone osteosarcomas: prognostic factors and early and long-term outcome.
    Salas S, Huynh TK, Giorgi R, Deville JL, Bollini G, Curvale G, Blesius A, Gentet JC, Bui B, Bouvier C, Duffaud F.
    Eur J Cancer Care (Engl); 2011 May 10; 20(3):322-9. PubMed ID: 20148934
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.
    Wu PK, Chen WM, Chen CF, Lee OK, Haung CK, Chen TH.
    Jpn J Clin Oncol; 2009 Aug 10; 39(8):514-22. PubMed ID: 19525290
    [Abstract] [Full Text] [Related]

  • 18. Prognostic relevance of increased angiogenesis in osteosarcoma.
    Kreuter M, Bieker R, Bielack SS, Auras T, Buerger H, Gosheger G, Jurgens H, Berdel WE, Mesters RM.
    Clin Cancer Res; 2004 Dec 15; 10(24):8531-7. PubMed ID: 15623635
    [Abstract] [Full Text] [Related]

  • 19. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma.
    Reddick WE, Wang S, Xiong X, Glass JO, Wu S, Kaste SC, Pratt CB, Meyer WH, Fletcher BD.
    Cancer; 2001 Jun 15; 91(12):2230-7. PubMed ID: 11413510
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.